why choose us

First received: June 07, 2023

Clinical Trial: A Clinical Study of ONCT-534 in Subjects With Metastatic Castration-resistant Prostate Cancer.

Study Status: Completed

Recruit Status: RECRUITING

Condition: Metastatic Castration-resistant Prostate Cancer

Study Type: INTERVENTIONAL


Official Title: A Phase 1/2 Study of ONCT-534 in Subjects With Metastatic Castration-Resistant Prostate Cancer

Brief Summary: A first-in-human clinical trial to test the investigational treatment ONCT-534 in participants with metastatic castration-resistant prostate cancer.The main questions it aims to answer are:What are the most tolerable doses of ONCT-534?(Phase 1)Does ONCT-534 have anti-tumor activity at tolerable doses?(Phase 2)This is a dose escalation and expansion study where participants will receive daily oral doses of ONCT-534.

Read more